Two Mutations can Explain CMML Incidence Age Dependence if Models Consider Intermediate Cell Clonal Expansion von Stiehl, T, Jackson, R.C, Maciejewski, J.P, Radivoyevitch, T

Volltext

Hypocupremia and bone marrow failure von Haddad, A.S, Subbiah, V, Lichtin, A.E, Theil, K.S, Maciejewski, J.P

Volltext

67 SUBCLASSIFICATION OF CHRONIC MYELOMONOCYTIC LEUKEMIA BY ANCESTRAL MUTATIONAL EVENTS von Patel, B, Huang, D, Thota, S, Przychodzen, B, Sakaguchi, H, Kojima, S, Ogawa, S, Sekeres, M.A, Makishima, H, Maciejewski, J.P

Volltext

79 RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE von Pleyer, C, Sidana, S, Erik, O, Radivoyevitch, T, Advani, A.S, Gerds, A.T, Carraway, H, Kalaycio, M, Maciejewski, J.P, Sekeres, M.A, Mukherjee, S

Volltext

310 RISK OF BONE MARROW FAILURE CONDITIONS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES von Ornstein, M.C, Mukherjee, S, Elson, P, Pierce, C, Zarzour, A, Saunthararajah, Y, Maggiotto, A, Hobson, S, Advani, A.S, Gerds, A.T, Carraway, H, Kalaycio, M, Maciejewski, J.P, Ellis, S, Blackstone, E, Sekeres, M.A

Volltext

Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders von Visconte, V, Makishima, H, Maciejewski, J P, Tiu, R V

Volltext

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms von Traina, F, Visconte, V, Elson, P, Tabarroki, A, Jankowska, A M, Hasrouni, E, Sugimoto, Y, Szpurka, H, Makishima, H, O'Keefe, C L, Sekeres, M A, Advani, A S, Kalaycio, M, Copelan, E A, Saunthararajah, Y, Olalla Saad, S T, Maciejewski, J P, Tiu, R V

Volltext

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells von Dolatshad, H, Pellagatti, A, Fernandez-Mercado, M, Yip, B H, Malcovati, L, Attwood, M, Przychodzen, B, Sahgal, N, Kanapin, A A, Lockstone, H, Scifo, L, Vandenberghe, P, Papaemmanuil, E, Smith, C W J, Campbell, P J, Ogawa, S, Maciejewski, J P, Cazzola, M, Savage, K I, Boultwood, J

Volltext

9 Clinical and pathogenetic implications of array-based karyotyping in MDS von Maciejewski, J.P, Jankowska, A, Makashima, H

Volltext

P-001 Next generation whole exome sequencing for recurrent somatic mutations on chromosome 7 von Hosono, N, Makishima, H, Jerez, A, Przychodzen, B, Gomez-Segui, I, Sekeres, M, Miyano, S, Shiraishi, Y, Ogawa, S, Yoshida, K, Maciejewski, J.P

Volltext

P-030 Novel mutations in spliceosomal gene PRPF8 show ring sideroblast phenotype in patients with myeloid neoplasms von Kozaric, A, Makishima, H, Przychodzen, B, Singh, J, Ogawa, S, Yoshida, K, Nakishima, M, Otrock, Z.K, Hsi, E, Padgett, R.A, Maciejewski, J.P

Volltext

P-146 Clinical and genetic characterization of 17 juvenile myelomonocytic leukemia patients with c-CBL mutations von Muramatsu, H, Sakaguchi, H, Xu, Y, Yoshida, K, Okuno, Y, Hama, A, Takahashi, Y, Makishima, H, Maciejewski, J.P, Ogawa, S, Kojima, S

Volltext

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts von Visconte, V, Makishima, H, Jankowska, A, Szpurka, H, Traina, F, Jerez, A, O'Keefe, C, Rogers, H J, Sekeres, M A, Maciejewski, J P, Tiu, R V

Volltext

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia von Andersson, E, Kuusanmäki, H, Bortoluzzi, S, Lagström, S, Parsons, A, Rajala, H, van Adrichem, A, Eldfors, S, Olson, T, Clemente, M J, Laasonen, A, Ellonen, P, Heckman, C, Loughran, T P, Maciejewski, J P, Mustjoki, S

Volltext

Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation von Radivoyevitch, T, Sachs, R K, Gale, R P, Molenaar, R J, Brenner, D J, Hill, B T, Kalaycio, M E, Carraway, H E, Mukherjee, S, Sekeres, M A, Maciejewski, J P

Volltext

PRPF8 defects cause missplicing in myeloid malignancies von Kurtovic-Kozaric, A, Przychodzen, B, Singh, J, Konarska, M M, Clemente, M J, Otrock, Z K, Nakashima, M, Hsi, E D, Yoshida, K, Shiraishi, Y, Chiba, K, Tanaka, H, Miyano, S, Ogawa, S, Boultwood, J, Makishima, H, Maciejewski, J P, Padgett, R A

Volltext

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies von Khan, S N, Jankowska, A M, Mahfouz, R, Dunbar, A J, Sugimoto, Y, Hosono, N, Hu, Z, Cheriyath, V, Vatolin, S, Przychodzen, B, Reu, F J, Saunthararajah, Y, O'Keefe, C, Sekeres, M A, List, A F, Moliterno, A R, McDevitt, M A, Maciejewski, J P, Makishima, H

Volltext

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides von Zeidan, A M, Sekeres, M A, Garcia-Manero, G, Steensma, D P, Zell, K, Barnard, J, Ali, N A, Zimmerman, C, Roboz, G, DeZern, A, Nazha, A, Jabbour, E, Kantarjian, H, Gore, S D, Maciejewski, J P, List, A, Komrokji, R

Volltext

Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia von Bilori, B, Thota, S, Clemente, M J, Patel, B, Jerez, A, Afable II, M, Maciejewski, J P

Volltext

Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms von Molenaar, R J, Thota, S, Nagata, Y, Patel, B, Clemente, M, Przychodzen, B, Hirsh, C, Viny, A D, Hosano, N, Bleeker, F E, Meggendorfer, M, Alpermann, T, Shiraishi, Y, Chiba, K, Tanaka, H, van Noorden, C J F, Radivoyevitch, T, Carraway, H E, Makishima, H, Miyano, S, Sekeres, M A, Ogawa, S, Haferlach, T, Maciejewski, J P

Volltext